In conclusion, we demonstrated that two transcripts, RAB32 and THBS1, conferred resistance to osimertinib by activating FAK signaling in NSCLC in vitro and possess potential as diagnostic biomarkers of osimertinib resistance in patients. The gene discussed is THBS1; the disease is non-small cell lung carcinoma.